Literature DB >> 19112954

Radiotherapy for perianal Paget's disease: a case report.

Vaneja Velenik1, Barbara Segedin, Franc Anderluh, Irena Oblak, Primoz Strojan.   

Abstract

BACKGROUND: Perianal Paget's disease was first described in 1893. Since then, fewer than 300 cases have been reported in the literature. It might be associated with an underlying malignancy. Most of the patients are treated with surgical excision, which is often mutilating and of variable efficacy. In the present report, we describe the case of an 80-year-old woman with perianal Paget's disease. She was treated at our institution with radiotherapy with curative intent. The pertinent literature is reviewed, and the controversies in diagnosis and management are discussed.
CONCLUSIONS: Our single-case experience supports the opinion that radiotherapy is a viable treatment option with curative potential for patients with perianal Paget's disease. For the treatment of in situ disease, hypofractionated regimens to a total dose of 40-44 Gy and orthovoltage X-ray beams are recommended.

Entities:  

Mesh:

Year:  2008        PMID: 19112954     DOI: 10.1177/030089160809400520

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  A hemorrhoid by any other name.

Authors:  Cameron D Adkisson; Ron G Landmann
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

2.  Management of penoscrotal extramammary Paget disease: case series and review of the literature.

Authors:  P Moretto; V J Nair; S El Hallani; S Malone; E Belanger; C Morash; C M Canil
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

3.  Perianal Paget disease treated definitively with radiotherapy.

Authors:  J Mann; A Lavaf; A Tejwani; P Ross; H Ashamalla
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

4.  HDR-plesiotherapy for the treatment of anogenital extramammary Paget's disease.

Authors:  Soraya Marcos; Angel Montero; Belén Capuz; Javier Martinez-Ollero; Raúl Hernanz; Eva Fernández; Alfredo Polo; Alfredo Ramos
Journal:  Rep Pract Oncol Radiother       Date:  2012-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.